New study pits CESM against MRI for breast cancer detection

NCT ID NCT05390229

First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 2 times

Summary

This study compared contrast-enhanced mammography (CESM) and magnetic resonance imaging (MRI) for diagnosing suspicious breast lesions in 231 women. Both imaging methods were evaluated against biopsy or surgery results to see which is more accurate. The goal is to determine if CESM could be a reliable alternative to MRI for breast cancer diagnosis.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

What this could lead to
If CESM proves as accurate as MRI, it could offer a faster, cheaper, and more accessible diagnostic option for suspicious breast lesions.
What could go wrong
This is a completed diagnostic comparison study, not a treatment trial. Results may show CESM is less accurate than MRI, and findings may not apply to all populations or settings.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for BREAST CANCER are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • St-Sacrement Hospital

    Québec, Quebec, G1S4L8, Canada

More trials for these conditions

Other studies related to the condition(s) this trial covers.